A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

Research output: Contribution to journalArticle


External organisations
  • Linköping University Hospital
  • Skåne University Hospital
  • Ryhov County Hospital, Jönköping
  • Karolinska University Hospital
  • Odense University Hospital
  • Växjö Central Hospital
  • Uppsala University
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)140-147
JournalAnnals of Oncology
Issue number1
Publication statusPublished - 2016 Jan
Publication categoryResearch
Externally publishedYes

Related research output

Helga Hagman, 2017, Lund: Lund University: Faculty of Medicine. 127 p.

Research output: ThesisDoctoral Thesis (compilation)

View all (1)